Topical Drug Delivery Market by Product (Liquid Formulations, Semi-Solid Formulations, Solid Formulations), Rout to Administration (Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery), End-User - Global Forecast 2024-2030

Topical Drug Delivery Market by Product (Liquid Formulations, Semi-Solid Formulations, Solid Formulations), Rout to Administration (Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery), End-User - Global Forecast 2024-2030


The Topical Drug Delivery Market size was estimated at USD 114.96 billion in 2023 and expected to reach USD 122.73 billion in 2024, at a CAGR 6.85% to reach USD 182.85 billion by 2030.

Global Topical Drug Delivery Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Topical Drug Delivery Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Topical Drug Delivery Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Topical Drug Delivery Market, highlighting leading vendors and their innovative profiles. These include Absorption Systems LLC, Bayer AG, Cipla Limited, Custom Converting, Inc., Galderma Laboratories, L.P., GlaxoSmithKline PLC, Glenmark Pharmaceuticals Limited, Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson Services, Inc., MedPharm Ltd., Mylan N.V., Novartis AG, Novartis International AG, Pfizer Inc., and The Lubrizol Corporation.

Market Segmentation & Coverage

This research report categorizes the Topical Drug Delivery Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
Liquid Formulations
Solutions

Suspensions
Semi-Solid Formulations
Creams

Gels

Lotions

Ointments

Pastes
Solid Formulations
Powders

Suppositories
Transdermal Products
Transdermal Patches

Transdermal Semi-Solids
Rout to Administration
Dermal Drug Delivery
Nasal Drug Delivery
Ophthalmic Drug Delivery
Rectal Drug Delivery
Vaginal Drug Delivery
End-User
Burn Centers
Home Care Settings
Hospitals & Clinics
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Topical Drug Delivery Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Topical Drug Delivery Market?
3. What are the technology trends and regulatory frameworks in the Topical Drug Delivery Market?
4. What is the market share of the leading vendors in the Topical Drug Delivery Market?
5. Which modes and strategic moves are suitable for entering the Topical Drug Delivery Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Topical Drug Delivery Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. High prevalence of skin and eye diseases and incidence of burn injuries
5.1.1.2. Preference for transdermal drug delivery
5.1.1.3. Need for medical self-administration and home care
5.1.2. Restraints
5.1.2.1. Preference for alternative modes of drug delivery
5.1.3. Opportunities
5.1.3.1. Funding and investments for drug delivery advancements
5.1.3.2. Development of improved targeted delivery of therapeutics
5.1.4. Challenges
5.1.4.1. Technical barriers related to skin irritation and permeability
5.1.4.2. Drug failures and product recalls
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Topical Drug Delivery Market, by Product
6.1. Introduction
6.2. Liquid Formulations
6.3.1. Solutions
6.3.2. Suspensions
6.3. Semi-Solid Formulations
6.4.1. Creams
6.4.2. Gels
6.4.3. Lotions
6.4.4. Ointments
6.4.5. Pastes
6.4. Solid Formulations
6.5.1. Powders
6.5.2. Suppositories
6.5. Transdermal Products
6.6.1. Transdermal Patches
6.6.2. Transdermal Semi-Solids
7. Topical Drug Delivery Market, by Rout to Administration
7.1. Introduction
7.2. Dermal Drug Delivery
7.3. Nasal Drug Delivery
7.4. Ophthalmic Drug Delivery
7.5. Rectal Drug Delivery
7.6. Vaginal Drug Delivery
8. Topical Drug Delivery Market, by End-User
8.1. Introduction
8.2. Burn Centers
8.3. Home Care Settings
8.4. Hospitals & Clinics
9. Americas Topical Drug Delivery Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Topical Drug Delivery Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Topical Drug Delivery Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Absorption Systems LLC
13.1.2. Bayer AG
13.1.3. Cipla Limited
13.1.4. Custom Converting, Inc.
13.1.5. Galderma Laboratories, L.P.
13.1.6. GlaxoSmithKline PLC
13.1.7. Glenmark Pharmaceuticals Limited
13.1.8. Hisamitsu Pharmaceutical Co., Inc.
13.1.9. Johnson & Johnson Services, Inc.
13.1.10. MedPharm Ltd.
13.1.11. Mylan N.V.
13.1.12. Novartis AG
13.1.13. Novartis International AG
13.1.14. Pfizer Inc.
13.1.15. The Lubrizol Corporation
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
FIGURE 1. TOPICAL DRUG DELIVERY MARKET RESEARCH PROCESS
FIGURE 2. TOPICAL DRUG DELIVERY MARKET SIZE, 2023 VS 2030
FIGURE 3. TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. TOPICAL DRUG DELIVERY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. TOPICAL DRUG DELIVERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. TOPICAL DRUG DELIVERY MARKET DYNAMICS
FIGURE 7. TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 10. TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. TOPICAL DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. TOPICAL DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings